Serum Folic Acid and RFC A80G Polymorphism in Alzheimer's Disease and Vascular Dementia. (February 2014)

• Record Type: Journal Article
• Authors: Mansoori, Nasim; Tripathi, Manjari; Alam, Rizwan; Luthra, Kalpana; Sharma, Sumit; Lakshmy, Ramakrishnan; Kalaivani, Mani; Mukhopadhyay, Asok K.
• Is Part Of: American journal of Alzheimer's disease & other dementias. Volume 29:Number 1(2014)
• Page Start: 38
• Page End: 44
• Publication Date: 2014-02
• Subjects: Alzheimer's disease -- vascular dementia -- folic acid -- vitamin B12 -- RFCA80G -- polymorphism; Alzheimer's disease -- Periodicals; Dementia -- Periodicals; Alzheimer's disease -- Patients -- Care -- United States -- Periodicals; 616.83
• DOI: 10.1177/1533317513505131
• Languages: English
• ISSNs: 1533-3175

Abstract

Low level of vitamin B12 and folic acid has been reported to play an important role in the pathogenesis of Alzheimer's disease (AD) and vascular dementia (VaD). Serum folic acid and vitamin B12 were assayed in 80 AD and 50 VaD cases and in 120 healthy controls. The reduced folate carrier ( RFC1 ) gene, rs1051266, which encodes the RFC 1, protein was analyzed for polymorphism by polymerase chain reaction–restriction fragment length polymorphism. It was observed that the patients having folic acid <8.45 ng/mL had 2.4 (95% confidence interval [CI]: 1.4-4.5) times higher odds of having AD and 2.1 (95% CI: 1.1-4.2) times higher odds of having VaD than patients having folic acid≥ 8.45 ng/mL. Serum vitamin B12 level did not show any such statistically significant effect in altering the odds. No direct association was found between variant (G) allele or genotype of rs1051266 with AD and VaD cases. On serum folate level no association was observed with gene polymorphism.